Document Detail


Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option.
MedLine Citation:
PMID:  11561738     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Lunelle, an injectable estrogen/progestin contraceptive, is administered on a monthly basis and is now available as the first monthly injectable in the United States. International and US clinical trials have established its safety and confirmed its contraceptive efficacy. Fertility returns rapidly after discontinuation of injections. Studies have noted a high level of patient satisfaction with Lunelle, suggesting that monthly injectable contraception will become a first-line contraceptive option in the United States.
Authors:
A M Kaunitz
Related Documents :
7966358 - Age-related acute adriamycin cardiotoxicity in mice.
23370608 - Blood stream infection is associated with altered heptavalent pneumococcal conjugate va...
24383988 - Cytokine responses of tnf-α, il-6, and il-10 in g6pd-deficient infants.
17158028 - Sperm quality, birth rates and the environment in flanders (belgium).
2308658 - Refractory congestive heart failure after ribavirin in infants with heart disease and r...
19925358 - Therapeutic closure of the ductus arteriosus: benefits and limitations.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  265     ISSN:  0932-0067     ISO Abbreviation:  Arch. Gynecol. Obstet.     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-09-19     Completed Date:  2002-01-16     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  119-23     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University of Florida, Jacksonville 32209, USA. andrew.kaunitz@jax.ufl.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Contraception
Contraceptive Agents, Female / administration & dosage*,  adverse effects
Drug Administration Schedule
Estradiol / administration & dosage*,  analogs & derivatives*
Female
Fertility / drug effects
Humans
Injections, Intramuscular
Medroxyprogesterone Acetate / administration & dosage*,  adverse effects
Patient Satisfaction
Pregnancy
Progesterone / blood
Time Factors
Treatment Outcome
Uterine Hemorrhage
Chemical
Reg. No./Substance:
0/Contraceptive Agents, Female; 0/Lunelle; 50-28-2/Estradiol; 57-83-0/Progesterone; 71-58-9/Medroxyprogesterone Acetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Perinatal mortality and morbidity. Comparison between maternal transport, neonatal transport and inp...
Next Document:  Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome.